Literature DB >> 14654942

Involvement of the mitogen-activated protein kinase kinase 2 in the induction of cell dissociation in pancreatic cancer.

Xiaodong Tan1, Hiroshi Egami, Hidenobu Kamohara, Shinji Ishikawa, Takashi Kurizaki, Naoya Yoshida, Yasuhiko Tamori, Eiji Takai, Masahiko Hirota, Michio Ogawa.   

Abstract

In our previous investigation, mitogen-activated protein kinase kinase 2 (MEK2) was detected as a factor which was correlated to the potential of invasion-metastasis. In this study, the immunocytochemical, immunohistochemical and mRNA expressions of MEK2 were examined in pancreatic cancer cell lines and tissue samples, respectively. Constitutive expressions of MEK2 and phosphorylated MEK (p-MEK) were observed in PC-1.0 and ASPC-1 cells, which exhibited a growth pattern of single cells, whereas the relevant expressions were quite faint in PC-1 cells and CAPAN-2 cells, which exhibited a growth pattern of island-like clonies. Simultaneous inductions of MEK2 expressions and cell dissociation were observed after the treatment with a conditioned medium (CM) of PC-1.0 cells. The expression of MEK2 and p-MEK were reduced and the cell aggregation was found in PC-1.0 and ASPC-1 cells after U0126 (a MEK inhibitor) treatment. In vivo, both the MEK2 and p-MEK overexpressed in human pancreatic cancer tissues and p-MEK was found to be more strongly expressed in the invasive front than that in the center of tumor (P<0.05). MEK2 is closely related to pancreatic cancer cell dissociation. MEK2 activation is probably involved in the first step of the cascade in the invasion-metastasis of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14654942

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  8 in total

1.  A novel activity from an old compound: Manzamine A reduces the metastatic potential of AsPC-1 pancreatic cancer cells and sensitizes them to TRAIL-induced apoptosis.

Authors:  Esther A Guzmán; Jacob D Johnson; Patricia A Linley; Sarath E Gunasekera; Amy E Wright
Journal:  Invest New Drugs       Date:  2010-03-30       Impact factor: 3.850

2.  Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway.

Authors:  X Tan; H Egami; M Abe; F Nozawa; M Hirota; M Ogawa
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

3.  Differential expression profiles of microRNAs in highly and weakly invasive/metastatic pancreatic cancer cells.

Authors:  Xiaodong Tan; Lei Zhou; Huaitao Wang; Yifan Yang; Yang Sun; Zhaoping Wang; Xiaobo Zhang; Feng Gao; Hansi Li
Journal:  Oncol Lett       Date:  2018-08-23       Impact factor: 2.967

4.  Genomic analysis of invasion-metastasis-related factors in pancreatic cancer cells.

Authors:  Xiaodong Tan; Lei Zhou; Wei Wang; Baosheng Wang; Hiroshi Egami; Hideo Baba; Xianwei Dai
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

5.  Phosphoproteome Analysis of Invasion and Metastasis-Related Factors in Pancreatic Cancer Cells.

Authors:  Xiaodong Tan; Peng Liu; Yinpeng Huang; Lei Zhou; Yifan Yang; Huaitao Wang; Boqiang Yu; Xiangli Meng; Xiaobo Zhang; Feng Gao
Journal:  PLoS One       Date:  2016-03-25       Impact factor: 3.240

6.  Quantitative secretomic analysis of pancreatic cancer cells in serum-containing conditioned medium.

Authors:  Peng Liu; Yejing Weng; Zhigang Sui; Yunhao Wu; Xiangli Meng; Mengwei Wu; Haoyi Jin; Xiaodong Tan; Lihua Zhang; Yukui Zhang
Journal:  Sci Rep       Date:  2016-11-21       Impact factor: 4.379

7.  Activation of MEK2 is sufficient to induce skin papilloma formation in transgenic zebrafish.

Authors:  Chih-Ming Chou; Yi-Chung Chen; San Su; Gen-Der Chen; Kai-Yun Huang; Huang-Wei Lien; Chang-Jen Huang; Chia-Hsiung Cheng
Journal:  J Biomed Sci       Date:  2015-11-17       Impact factor: 8.410

8.  Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer.

Authors:  Haoyi Jin; Peng Liu; Yunhao Wu; Xiangli Meng; Mengwei Wu; Jiahong Han; Xiaodong Tan
Journal:  Cancer Sci       Date:  2018-09       Impact factor: 6.716

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.